Search Results - Cemile Bathelt
- Showing 1 - 4 results of 4
-
1
-
2
Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial by Julie Refardt, Cornelia Imber, Rianne Nobbenhuis, Clara Odilia Sailer, Aaron Haslbauer, Sophie Monnerat, Cemile Bathelt, D. Vogt, Manfred Berres, Bettina Winzeler, Stephanie A. Bridenbaugh, Mirjam Christ‐Crain
Published 2022Artigo -
3
Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial by Sophia Lengsfeld, Thilo Burkard, Andrea Meienberg, Nica Jeanloz, Tanja Vukajlovic, Katja Bologna, Michelle Steinmetz, Cemile Bathelt, Clara Odilia Sailer, D. Vogt, Lars G. Hemkens, Benjamin Speich, Sandrine Urwyler, Jill Kühne, Fabienne Baur, Linda N. Lutz, Tobias E. Erlanger, Mirjam Christ‐Crain, Bettina Winzeler
Published 2023Artigo -
4
Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial by H Lüthi, Sophia Lengsfeld, Thilo Burkard, Andrea Meienberg, Nica Jeanloz, Tanja Vukajlovic, Katja Bologna, Michelle Steinmetz, Cemile Bathelt, Clara Odilia Sailer, Mirjam Laager, D. Vogt, Lars G. Hemkens, Benjamin Speich, Sandrine Urwyler, Jill Kühne, Fabienne Baur, Linda N. Lutz, Tobias E. Erlanger, Mirjam Christ‐Crain, Bettina Winzeler
Published 2024Artigo
Search Tools:
Related Subjects
Alternative medicine
Internal medicine
Medicine
Pathology
Placebo
Randomized controlled trial
Diabetes mellitus
Endocrinology
Type 2 diabetes
Abstinence
Double blind
Dulaglutide
Physical therapy
Psychiatry
Smoking cessation
Addiction
Agonist
Body weight
Clinical endpoint
Confidence interval
Craving
Crossover study
Empagliflozin
Exenatide
Free water clearance
Glucagon-like peptide 1 receptor
Hyponatremia
Liraglutide
Placebo group
Placebo-controlled study